Corvus Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Annual) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

25.10 -0.42 (-1.65%) USD | NASDAQ | Jan 23, 16:00

25.19 +0.09 (+0.36%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Plus Therapeutics, Inc.	Upgrade
Geron Corp.	Upgrade
Jaguar Health, Inc.	Upgrade
Rapt Therapeutics, Inc.	Upgrade